THIOREDOXIN AND THIOREDOXIN REDUCTASE IN THE PATHOGENESIS OF SELECTED HUMAN DISEASES, PART II

被引:0
|
作者
Popielarski, Marcin [1 ]
Ponamarczuk, Halszka [1 ]
Kusinska, Katarzyna [1 ]
Swiatkowska, Maria [1 ]
机构
[1] Uniwersytet Med & Lodzi, Zaklad Cytobiol & Prote, Katedra Nauk Biomed, Ul Mazowiecka 6-8, PL-92215 Lodz, Poland
关键词
thioredoxin; thioredoxin reductase; cancers; oxidative stress; apoptosis; CANCER-CELL-GROWTH; 1-METHYLPROPYL 2-IMIDAZOLYL DISULFIDE; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; MITOCHONDRIAL COMPLEX-III; MAMMALIAN THIOREDOXIN; ARSENIC TRIOXIDE; ORGANOTELLURIUM COMPOUNDS; MOTEXAFIN GADOLINIUM; MOLECULAR-MECHANISMS; GOLD(I) COMPLEXES;
D O I
暂无
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Thioredoxin and thioredoxin reductase form a thioredoxin system, which is involved in protecting cells against oxidative stress, regulation of apoptosis and regulation of tumorigenesis. Defects in thioredoxin system are associated with the pathogenesis of many human diseases, including the development of cancer. Overexpression of thioredoxin and thioredoxin reductase leads to increased proliferation, angiogenesis and initiation of anti-apoptotic pathways. Increased levels of thioredoxin and thioredoxin reductase are considered to be one of the mechanisms correlated with drug resistance in malignant cells. We can observe growing evidences suggesting the role of thioredoxin and thioredoxin reductase inhibitors in treatment of tumors. Results of therapy using thioredoxin and thioredoxin reductase inhibitors seems to be very promising.
引用
收藏
页码:159 / 179
页数:21
相关论文
共 50 条
  • [1] Methylglyoxal Causes Dysfunction of Thioredoxin and Thioredoxin Reductase in Endothelial Cells
    Tatsunami, Ryosuke
    Oba, Tatsuya
    Takahashi, Kyohei
    Tampo, Yoshiko
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2009, 111 (04) : 426 - 432
  • [2] Fluorogenic probes for thioredoxin reductase activity
    Mafireyi, Tendai J.
    Escobedo, Jorge O.
    Strongin, Robert M.
    RESULTS IN CHEMISTRY, 2021, 3
  • [3] The thioredoxin reductase/thioredoxin system - Novel redox targets for cancer therapy
    Biaglow, JE
    Miller, RA
    CANCER BIOLOGY & THERAPY, 2005, 4 (01) : 6 - 13
  • [4] Thioredoxin reductase as a pharmacological target
    Bjorklund, Geir
    Zou, Lili
    Wang, Jun
    Chasapis, Christos T.
    Peana, Massimiliano
    PHARMACOLOGICAL RESEARCH, 2021, 174
  • [5] Mechanistic insights into the inhibitory effects of palmitoylation on cytosolic thioredoxin reductase and thioredoxin
    Qin, Huijun
    Liang, Wei
    Xu, Zhiyu
    Ye, Fei
    Li, Xiaoming
    Zhong, Liangwei
    BIOCHIMIE, 2015, 110 : 25 - 35
  • [6] Thioredoxin/thioredoxin reductase system involvement in cerebellar granule cell apoptosis
    Bobba, A.
    Casalino, E.
    Petragallo, V. A.
    Atlante, A.
    APOPTOSIS, 2014, 19 (10) : 1497 - 1508
  • [7] Physiological functions of thioredoxin and thioredoxin reductase
    Arnér, ESJ
    Holmgren, A
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 2000, 267 (20): : 6102 - 6109
  • [8] A thioredoxin reductase and/or thioredoxin system-based mechanism for antioxidant effects of ambroxol
    Huang, Jin
    Xu, Jianying
    Tian, Lin
    Zhong, Liangwei
    BIOCHIMIE, 2014, 97 : 92 - 103
  • [9] Thioredoxin and thioredoxin reductase: Current research with special reference to human disease
    Holmgren, Arne
    Lu, Jun
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 396 (01) : 120 - 124
  • [10] Characterization of thioredoxin-thioredoxin reductase system in Filifactor alocis
    Mishra, Arunima
    Dou, Yuetan
    Fletcher, Hansel M.
    MOLECULAR ORAL MICROBIOLOGY, 2025, 40 (01) : 50 - 63